Business

Resverlogix Announces Closing of Debt Redemption

TSX Exchange Symbol: RVX CALGARY, Oct. 17 /CNW/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) ann...

articleResverlogix Corp.October 17, 20084/company/resverlogix-corp/news/resverlogix-announces-closing-of-debt-redemption
Resverlogix Announces Closing of Debt Redemption

About this update from Resverlogix Corp.

[{"type":"text","content":"\n\n\n\nTSX Exchange Symbol: RVX\n\n\nCALGARY, Oct. 17 /CNW/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX)\nannounced today that the Toronto Stock Exchange has approved Resverlogix's\nprevious announcement on October 15, 2008 regarding the redeeming of\nUS $10 million of its remaining US $17.3 million debenture. The remaining\nbalance of the debenture including accrued interest earned to October 14, 2008\nis US $7.89 million.\n\n\nTo assist shareholders with understanding the salient and beneficial\npoints to this amendment Resverlogix will post key facts to SEDAR.\n\n\nRodman & Renshaw, LLC served as an advisor to the company.\n\n\nAbout Resverlogix Corp.\n\n\nResverlogix Corp. is a leading biotechnology company engaged in the\ndevelopment of novel therapies for important global medical markets with\nsignificant unmet needs. The NexVas(TM) program is the Company's primary focus\nwhich is to develop novel small molecules that enhance ApoA-I. These vital\ntherapies address the grievous burden of atherosclerosis and other important\ndiseases such as acute coronary syndrome, diabetes, Alzheimer's disease and\nother vascular disorders. The Company's secondary focus is TGF-Beta\nShield(TM), a program that aims to address burgeoning grievous diseases, such\nas cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange\n(TSX:RVX). For further information please visit www.resverlogix.com.\n\n\nThis news release may contain certain forward-looking statements that\nreflect the current views and/or expectations of Resverlogix Corp. with\nrespect to its performance, business and future events. Such statements are\nsubject to a number of risks, uncertainties and assumptions. Actual results\nand events may vary significantly. The TSX Exchange does not accept\nresponsibility for the adequacy or accuracy of this news release.\n\n\n%SEDAR: 00019253E\n\n\n","length":1952,"tagName":"div"}]

More updates from Resverlogix Corp.